BPC 157 has been showing up more and more in performance and rehab circles, often hyped as a game changer for soft tissue recovery. Jordan Sabourin, PhD The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Bpc 157 and TB 500 My protocol and results explained! I've talked about this with probably a dozen different guys over the last 4 months so hopefully this helps someone else. #progress # FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology